We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT

By MedImaging International staff writers
Posted on 25 Mar 2024
Print article
Image: AIxScan leverages cutting-edge AI and hardware advancements to redefine X-ray imaging (Photo courtesy of AIxSCAN)
Image: AIxScan leverages cutting-edge AI and hardware advancements to redefine X-ray imaging (Photo courtesy of AIxSCAN)

A groundbreaking intelligent tomosynthesis X-ray imaging system aims to seamlessly blend the capabilities of digital radiography (DR), computerized tomography (CT), and the expertise of a seasoned radiologist in one smart package. This integrated system could deliver accountable and consistent diagnostic reports within seconds of scanning the patient.

AIxSCAN, Inc. (Sunnyvale, CA, USA) is introducing ARC60, an AI-based tomosynthesis X-ray imaging system that combines the functionalities of DR, CT, and an experienced radiologist into a single package. This direct AI-based medical X-ray imaging system, which marks a paradigm shift from conventional DR and CT, aims to enable accurate diagnoses and tracking of abnormalities over time. This technology will allow the radiologist to complete a scan, assist the physician in providing a diagnosis, and create a report efficiently and at a low radiation dose (from 1/20 to 1/40 that of a typical CT).

AIxScan leverages cutting-edge AI and hardware advancements to redefine X-ray imaging. By optimizing algorithms, the ARC60 system achieves short screening times, large-angle imaging, and ultra-high resolution, resulting in quick and accurate diagnostics. The integration of AI-driven dose optimization improves safety with ultra-low-dose X-ray exposure, while a standalone unit with high mobility, combined with cost-effective acquisition and ownership, marks a groundbreaking shift, making advanced medical imaging more affordable and accurate. The early ARC60 imaging results from clinical trials that began in late 2023 have been encouraging, both in terms of depiction of details and consistency of imaging quality. Between late 2023 and early 2024, AIxSCAN plans to produce over 50 lung disease patient scans in the U.S. and up to 1,000 total lung disease patient scans within two years. The company will use some of the data to support its 510k submission to the FDA in 2024.

“This innovative technology has the potential to change the way we diagnose a range of medical conditions,” said Norbert Pelc, Sc.D., Professor of Radiology, Emeritus at Stanford University and AIxSCAN Advisory Board member. “The AIxSCAN tomosynthesis X-ray scanner does not completely avoid the superimposition limitations of radiography, but the early results from the prototype system are very encouraging and suggest the technology can play a significant role. I believe that AIxSCAN's tomosynthesis X-ray scanner has a very good chance of becoming a valuable tool for the medical community. This technology has the potential to improve patient care and save lives.”

 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Table
Powered Ultrasound Table-Flat Top
New
Breast Imaging Workstation
SecurView
Thyroid Shield
Standard Thyroid Shield

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

General/Advanced Imaging

view channel
Image: The Tyche machine-learning model could help capture crucial information. (Photo courtesy of 123RF)

New AI Method Captures Uncertainty in Medical Images

In the field of biomedicine, segmentation is the process of annotating pixels from an important structure in medical images, such as organs or cells. Artificial Intelligence (AI) models are utilized to... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.